HPV相关舌根癌经口手术后对侧隐匿性淋巴结转移风险与发生率
该回顾性病例系列纳入89例HPV相关舌根鳞癌患者,均接受经口手术与双侧颈清扫。38.2%存在对侧病理淋巴结转移,临床阴性者中21.4%为隐匿性转移;肿瘤过中线者风险更高(OR 6.23)。作者建议对侧选择性颈清扫或放疗。
要点
- HPV相关舌根癌对侧隐匿性淋巴结转移率达21.4%。
- 肿瘤过中线显著增加对侧转移风险(OR 6.23)。
- 对侧颈清扫病理阴性者或可免于对侧放疗。
核心结论
- HPV相关舌根癌对侧隐匿性淋巴结转移率为21.4%,建议行对侧选择性颈清扫或放疗。
- 对侧颈清扫病理阴性者可能不需对该侧淋巴结区行放疗。
研究设计与样本
- 患者均接受经口手术与双侧颈清扫,中位随访30.0个月(IQR 11.0-60.4个月)。
- 排除复发或多原发同步OPSCC患者。
主要发现
- 89例中81例(91.0%)为男性,平均(SD)年龄60(9)岁。
- 34例(38.2%)有对侧病理淋巴结转移。
- 70例无对侧临床证据者中15例(21.4%)发现隐匿性淋巴结。
- 肿瘤过中线者对侧转移风险更高(OR 6.23;95%CI 1.71-22.77)。
- 55例无隐匿病变者中仅2例(3.6%)接受对侧颈放疗,未见区域复发。
临床怎么用
- 对HPV相关舌根癌应评估对侧颈部,考虑对侧选择性颈清扫或放疗。
- 肿瘤过中线者可重点关注对侧转移风险。
- 对侧颈清扫病理阴性者或可省略对侧放疗。
局限性
- 回顾性病例系列设计。
- 单中心三级医疗中心数据。
- 样本量89例,随访时间有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The optimal treatment strategy for patients with human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) of the base of the tongue (BOT) has not been sufficiently studied. OBJECTIVE: To investigate the rate of and risk factors for occult contralateral nodal disease in patients with HPV-related BOT OPSCC undergoing transoral surgery and bilateral neck dissections. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case series reviewed the medical records of patients with HPV-related BOT OPSCC who underwent transoral surgery and bilateral neck dissections from January 1, 2002, through December 31, 2018, at the tertiary care center of Washington University School of Medicine in St Louis. Patients had a median follow-up of 30.0 months (interquartile range, 11.0-60.4 months). Patients with recurrent disease or multiple synchronous OPSCC primary tumors were excluded for a total of 89 patients. Data were analyzed from January 1 through June 1, 2019. MAIN OUTCOMES AND MEASURES: The primary outcome was the rate of contralateral occult nodal disease. Secondary outcomes were potential risk factors for contralateral occult nodal disease and regional recurrence rates. RESULTS: Eighty-nine patients were included in the series, of whom 81 (91.0%) were men. The mean (SD) age was 60 (9) years. Overall, 34 patients (38.2%) had pathologic contralateral nodal metastases. Seventy patients had no clinical evidence of contralateral nodal disease. Of these 70, occult nodes were identified in 15 (21.4%). Risk of contralateral disease was higher when the primary tumor crossed midline (odds ratio, 6.23; 95% CI, 1.71-22.77). Of the 55 patients with no occult disease identified, only 2 (3.6%) received radiotherapy to the contralateral neck, and no regional recurrence of disease was noted. CONCLUSIONS AND RELEVANCE: Given the rate of occult contralateral nodal disease of 21.4%, it appears that contralateral elective neck dissection or radiotherapy should be recommended in patients with HPV-related BOT OPSCC. Patients with a pathologically negative result of contralateral neck dissection may not benefit from radiotherapy to that nodal basin. Future prospective investigations should evaluate functional and oncologic outcomes of contralateral elective neck dissection compared with elective radiotherapy in the contralateral neck for HPV-related BOT OPSCC.
引用
- Last AS, Pipkorn P, Chen S, et al. Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus-Related Squamous Cell Carcinoma of the Base of the Tongue. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31697348. doi:10.1001/jamaoto.2019.3277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。